Bottom line
What is OBIOX's expense ratio?
OBIOX's expense ratio is 1.35%, or about $135 a year on every $10,000 invested. That is more expensive than 84% of international stock funds we track (median 0.9%). Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Apr 30, 2026
OBIOX fee table
| Net expense ratio | 1.35% |
|---|---|
| Gross expense ratio | 1.43% |
| Management fee | 1% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.18% |
| Fee waiver / reimbursement | -0.08% |
| Redemption fee | -2% |
Source: Fund prospectus fee table, filed Apr 30, 2026
What OBIOX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| OBIOX | $137 | $445 | $774 | $1,706 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.35% expense ratio costs roughly $72,500 in lost growth, versus about $50,300 for the median international stock fund (0.9%).